SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Aclaris Therapeutics, Inc. – ‘10-Q’ for 6/30/22

On:  Wednesday, 8/3/22, at 7:30am ET   ·   For:  6/30/22   ·   Accession #:  1558370-22-11757   ·   File #:  1-37581

Previous ‘10-Q’:  ‘10-Q’ on 5/10/22 for 3/31/22   ·   Next:  ‘10-Q’ on 11/8/22 for 9/30/22   ·   Latest:  ‘10-Q’ on 11/6/23 for 9/30/23   ·   5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/03/22  Aclaris Therapeutics, Inc.        10-Q        6/30/22   72:7.6M                                   Toppan Merrill Bridge/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.76M 
 2: EX-10.1     Material Contract                                   HTML    117K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
11: R1          Document and Entity Information                     HTML     72K 
12: R2          Condensed Consolidated Balance Sheets               HTML    123K 
13: R3          Condensed Consolidated Balance Sheets               HTML     37K 
                (Parenthetical)                                                  
14: R4          Condensed Consolidated Statements of Operations     HTML    100K 
                and Comprehensive Loss                                           
15: R5          Condensed Consolidated Statements of Operations     HTML     22K 
                and Comprehensive Loss (Parenthetical)                           
16: R6          Condensed Consolidated Statements of Stockholders'  HTML     96K 
                Equity                                                           
17: R7          Condensed Consolidated Statements of Stockholders'  HTML     24K 
                Equity (Parenthetical)                                           
18: R8          Condensed Consolidated Statements of Cash Flows     HTML     90K 
19: R9          Organization and Nature of Business                 HTML     28K 
20: R10         Summary of Significant Accounting Policies          HTML     32K 
21: R11         Fair Value of Financial Assets and Liabilities      HTML    172K 
22: R12         Property and Equipment, Net                         HTML     40K 
23: R13         Intangible Assets                                   HTML     59K 
24: R14         Accrued Expenses                                    HTML     35K 
25: R15         Debt                                                HTML     27K 
26: R16         Stockholders' Equity                                HTML     34K 
27: R17         Stock-Based Awards                                  HTML    123K 
28: R18         Net Loss per Share                                  HTML     57K 
29: R19         Leases                                              HTML     42K 
30: R20         Agreements Related to Intellectual Property         HTML     27K 
31: R21         Income Taxes                                        HTML     25K 
32: R22         Discontinued Operations                             HTML     31K 
33: R23         Segment Information                                 HTML    137K 
34: R24         Legal Proceedings                                   HTML     28K 
35: R25         Summary of Significant Accounting Policies          HTML     39K 
                (Policies)                                                       
36: R26         Fair Value of Financial Assets and Liabilities      HTML    169K 
                (Tables)                                                         
37: R27         Property and Equipment, Net (Tables)                HTML     38K 
38: R28         Intangible Assets (Tables)                          HTML     60K 
39: R29         Accrued Expenses (Tables)                           HTML     34K 
40: R30         Stock-Based Awards (Tables)                         HTML    123K 
41: R31         Net Loss per Share (Tables)                         HTML     58K 
42: R32         Leases (Tables)                                     HTML     40K 
43: R33         Discontinued Operations (Tables)                    HTML     33K 
44: R34         Segment Information (Tables)                        HTML    131K 
45: R35         Organization and Nature of Business (Details)       HTML     27K 
46: R36         Summary of Significant Accounting Policies          HTML     26K 
                (Details)                                                        
47: R37         Fair Value of Financial Assets and Liabilities      HTML     52K 
                (Details)                                                        
48: R38         Fair Value of Financial Assets and Liabilities -    HTML     46K 
                By Type (Details)                                                
49: R39         Property and Equipment, Net (Details)               HTML     41K 
50: R40         Intangible Assets (Details)                         HTML     39K 
51: R41         Intangible Assets - Future Amortization Expenses    HTML     41K 
                (Details)                                                        
52: R42         Accrued Expenses (Details)                          HTML     32K 
53: R43         Debt (Details)                                      HTML     32K 
54: R44         Stockholders' Equity (Details)                      HTML     46K 
55: R45         Stockholders' Equity - Other Offerings and ATM      HTML     44K 
                Facility (Details)                                               
56: R46         Stock-Based Awards (Details)                        HTML     65K 
57: R47         Stock-Based Awards - Option Activity (Details)      HTML     77K 
58: R48         Stock-Based Awards - RSUs (Details)                 HTML     46K 
59: R49         Stock-Based Awards - Compensation (Details)         HTML     42K 
60: R50         Net Loss per Share (Details)                        HTML     52K 
61: R51         Net Loss per Share - Anti-dilution (Details)        HTML     28K 
62: R52         Leases (Details)                                    HTML     47K 
63: R53         Agreements Related to Intellectual Property         HTML     44K 
                (Details)                                                        
64: R54         Income Taxes (Details)                              HTML     25K 
65: R55         Discontinued Operations - Assets and Liabilities    HTML     27K 
                (Details)                                                        
66: R56         Segment Information (Details)                       HTML     59K 
67: R57         Legal Proceedings (Details)                         HTML     28K 
70: XML         IDEA XML File -- Filing Summary                      XML    127K 
68: XML         XBRL Instance -- acrs-20220630x10q_htm               XML   1.91M 
69: EXCEL       IDEA Workbook of Financial Reports                  XLSX    111K 
 7: EX-101.CAL  XBRL Calculations -- acrs-20220630_cal               XML    131K 
 8: EX-101.DEF  XBRL Definitions -- acrs-20220630_def                XML    502K 
 9: EX-101.LAB  XBRL Labels -- acrs-20220630_lab                     XML   1.04M 
10: EX-101.PRE  XBRL Presentations -- acrs-20220630_pre              XML    728K 
 6: EX-101.SCH  XBRL Schema -- acrs-20220630                         XSD    130K 
71: JSON        XBRL Instance as JSON Data -- MetaLinks              334±   516K 
72: ZIP         XBRL Zipped Folder -- 0001558370-22-011757-xbrl      Zip    314K 




        
Filing Submission 0001558370-22-011757 – SGML Text

Original SGML Text submitted by:  Toppan Merrill Bridge/FA  (as Filing Agent) 

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 5, 12:17:33.3pm ET